Literature DB >> 24882466

Disruption of Pten speeds onset and increases severity of spontaneous colitis in Il10(-/-) mice.

Eunok Im1, Jane Jung2, Charalabos Pothoulakis2, Sang Hoon Rhee3.   

Abstract

BACKGROUND & AIMS: Early-onset ulcerative colitis, which is considered severe colonic inflammation that develops in infants and young children, can be caused by alterations in interleukin (IL)-10 signaling, although other factors are involved in its pathogenesis. We investigated whether loss of phosphatase and tensin homologue (PTEN), which regulates many important cell functions such as cell proliferation, cell survival, and Toll-like receptor (TLR) signaling pathways, contributes to the development of colitis in Il10(-/-) mice.
METHODS: We generated Il10(-/-) mice (in C57BL/6 and C3H/HeJBir background strains) with disruption of Pten in the intestinal epithelium (Ints(ΔPtenPten);Il10(-/-) mice) and Ints(ΔCont);Il10(-/-) (control) mice. Colon tissues were collected and histological, transmission electron microscopy, and gene expression analysis were performed. Fecal microbiota samples were analyzed by sequencing of 16S ribosomal RNA genes. We disrupted Tlr4 in Ints(ΔPtenPten);Il10(-/-) mice. Lipopolysaccharide signaling via TLR4 was blocked by treating mice with polymyxin B.
RESULTS: Il10(-/-) mice developed colitis when they were 6 to 7 months old, whereas Ints(ΔPtenPten);Il10(-/-) mice developed severe colitis and colon tumors by the time they were 36 days old. Within 3 months of birth, 80% of Ints(ΔPtenPten);Il10(-/-) mice developed severe colitis and colonic malignancy, whereas none of the Ints(ΔCont);Il10(-/-) mice had these phenotypes. Ints(ΔPtenPten);Il10(-/-) mice had alterations in fecal microbiota compared with controls, such as increased proportions of Bacteroides species, which are gram negative. Disruption of Tlr4 or treating Ints(ΔPtenPten);Il10(-/-) mice with polymyxin B delayed the development of colitis and reduced disease severity.
CONCLUSIONS: Disruption of Pten in the intestinal epithelium of Il10(-/-) mice speeds the onset and increases the severity of colitis. Fecal microbiota from Ints(ΔPtenPten);Il10(-/-) mice have increased proportions of Bacteroides species. Development of colitis is delayed and reduced by blocking TLR4 signaling. Ints(ΔPtenPten);Il10(-/-) mice may be studied as a model for early-onset ulcerative colitis and used to identify new therapeutic targets.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammatory Bowel Disease; Innate Immunity; Intestinal Epithelial Cells; Pediatric

Mesh:

Substances:

Year:  2014        PMID: 24882466      PMCID: PMC4143453          DOI: 10.1053/j.gastro.2014.05.034

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  36 in total

1.  Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease.

Authors:  Bernadette Begue; Julien Verdier; Frédéric Rieux-Laucat; Olivier Goulet; Alain Morali; Danielle Canioni; Jean-Pierre Hugot; Cécile Daussy; Virginie Verkarre; Bénédicte Pigneur; Alain Fischer; Christoph Klein; Nadine Cerf-Bensussan; Frank M Ruemmele
Journal:  Am J Gastroenterol       Date:  2011-04-26       Impact factor: 10.864

Review 2.  Optimization of conventional therapy in patients with IBD.

Authors:  Kirstin M Taylor; Peter M Irving
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

3.  Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice.

Authors:  Eunok Im; Franz Martin Riegler; Charalabos Pothoulakis; Sang Hoon Rhee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-21       Impact factor: 4.052

4.  Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia.

Authors:  Gernot Schabbauer; Ulrich Matt; Philipp Günzl; Joanna Warszawska; Tanja Furtner; Eva Hainzl; Immanuel Elbau; Ildiko Mesteri; Bianca Doninger; Bernd R Binder; Sylvia Knapp
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

Review 5.  Structure--activity relationships of polymyxin antibiotics.

Authors:  Tony Velkov; Philip E Thompson; Roger L Nation; Jian Li
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

6.  WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe.

Authors:  Philip C De Witt Hamer; Shahryar E Mir; David Noske; Cornelis J F Van Noorden; Tom Würdinger
Journal:  Clin Cancer Res       Date:  2011-05-11       Impact factor: 12.531

Review 7.  Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease.

Authors:  Neil Shah; Jochen Kammermeier; Mamoun Elawad; Erik-Oliver Glocker
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

8.  Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.

Authors:  Daniel Kotlarz; Rita Beier; Dhaarini Murugan; Jana Diestelhorst; Ole Jensen; Kaan Boztug; Dietmar Pfeifer; Hans Kreipe; Eva-Doreen Pfister; Ulrich Baumann; Jacek Puchalka; Jens Bohne; Odul Egritas; Buket Dalgic; Kaija-Leena Kolho; Axel Sauerbrey; Stephan Buderus; Tayfun Güngör; Axel Enninger; Yu Kar Ling Koda; Graziella Guariso; Batia Weiss; Selim Corbacioglu; Piotr Socha; Nuray Uslu; Ayse Metin; Ghassan T Wahbeh; Khalid Husain; Dina Ramadan; Waleed Al-Herz; Bodo Grimbacher; Martin Sauer; Karl-Walter Sykora; Sibylle Koletzko; Christoph Klein
Journal:  Gastroenterology       Date:  2012-04-28       Impact factor: 22.682

9.  PTEN regulates TLR5-induced intestinal inflammation by controlling Mal/TIRAP recruitment.

Authors:  Yoon Jeong Choi; Jane Jung; Hyo Kyun Chung; Eunok Im; Sang Hoon Rhee
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

10.  Intestinal inflammation targets cancer-inducing activity of the microbiota.

Authors:  Janelle C Arthur; Ernesto Perez-Chanona; Marcus Mühlbauer; Sarah Tomkovich; Joshua M Uronis; Ting-Jia Fan; Barry J Campbell; Turki Abujamel; Belgin Dogan; Arlin B Rogers; Jonathan M Rhodes; Alain Stintzi; Kenneth W Simpson; Jonathan J Hansen; Temitope O Keku; Anthony A Fodor; Christian Jobin
Journal:  Science       Date:  2012-08-16       Impact factor: 47.728

View more
  20 in total

1.  Pten gene deletion in intestinal epithelial cells enhances susceptibility to Salmonella Typhimurium infection in mice.

Authors:  Cody Howe; Jonathon Mitchell; Su Jin Kim; Eunok Im; Sang Hoon Rhee
Journal:  J Microbiol       Date:  2019-09-25       Impact factor: 3.422

2.  Colonic Inhibition of Phosphatase and Tensin Homolog Increases Colitogenic Bacteria, Causing Development of Colitis in Il10-/- Mice.

Authors:  Jonathon Mitchell; Su Jin Kim; Georgios Koukos; Alexandra Seelmann; Brendan Veit; Brooke Shepard; Sara Blumer-Schuette; Harland S Winter; Dimitrios Iliopoulos; Charalabos Pothoulakis; Eunok Im; Sang Hoon Rhee
Journal:  Inflamm Bowel Dis       Date:  2018-07-12       Impact factor: 5.325

Review 3.  Chronic inflammation and the development of malignancy in the GI tract.

Authors:  Stefan Fichtner-Feigl; Rebecca Kesselring; Warren Strober
Journal:  Trends Immunol       Date:  2015-07-18       Impact factor: 16.687

4.  Chronic Intestinal Inflammation Suppresses Brain Activity by Inducing Neuroinflammation in Mice.

Authors:  Jonathon Mitchell; Su Jin Kim; Cody Howe; Seulah Lee; Ji Yun Her; Marisa Patel; Gayoung Kim; Jaewon Lee; Eunok Im; Sang Hoon Rhee
Journal:  Am J Pathol       Date:  2021-10-05       Impact factor: 4.307

5.  Autotaxin loss accelerates intestinal inflammation by suppressing TLR4-mediated immune responses.

Authors:  Su Jin Kim; Cody Howe; Jonathon Mitchell; Jieun Choo; Alexandra Powers; Angelos Oikonomopoulos; Charalabos Pothoulakis; Daniel W Hommes; Eunok Im; Sang Hoon Rhee
Journal:  EMBO Rep       Date:  2020-09-01       Impact factor: 8.807

6.  MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.

Authors:  Christos Polytarchou; Daniel W Hommes; Tiziana Palumbo; Maria Hatziapostolou; Marina Koutsioumpa; Georgios Koukos; Andrea E van der Meulen-de Jong; Angelos Oikonomopoulos; Welmoed K van Deen; Christina Vorvis; Oksana B Serebrennikova; Eleni Birli; Jennifer Choi; Lin Chang; Peter A Anton; Philip N Tsichlis; Charalabos Pothoulakis; Hein W Verspaget; Dimitrios Iliopoulos
Journal:  Gastroenterology       Date:  2015-06-06       Impact factor: 22.682

7.  Differential expression of tumor-associated genes and altered gut microbiome with decreased Akkermansia muciniphila confer a tumor-preventive microenvironment in intestinal epithelial Pten-deficient mice.

Authors:  Cody Howe; Su Jin Kim; Jonathon Mitchell; Eunok Im; Yong Sung Kim; You Sun Kim; Sang Hoon Rhee
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-10-04       Impact factor: 5.187

Review 8.  Genetics and Pathogenesis of Inflammatory Bowel Disease.

Authors:  Ta-Chiang Liu; Thaddeus S Stappenbeck
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

Review 9.  Phosphatase and Tensin Homolog in Non-neoplastic Digestive Disease: More Than Just Tumor Suppressor.

Authors:  Tianyu He; Xiaoyun Zhang; Jianyu Hao; Shigang Ding
Journal:  Front Physiol       Date:  2021-06-01       Impact factor: 4.566

10.  Natural genetic variation drives microbiome selection in the Caenorhabditis elegans gut.

Authors:  Fan Zhang; Jessica L Weckhorst; Adrien Assié; Ciara Hosea; Christopher A Ayoub; Anastasia S Khodakova; Mario Loeza Cabrera; Daniela Vidal Vilchis; Marie-Anne Félix; Buck S Samuel
Journal:  Curr Biol       Date:  2021-05-27       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.